Cardiovascular(心血管)
Cardiovascular
The cardiovascular system consists of the heart, blood and blood vessels. These organs form the 3 major closed circulation systems in the body, i.e., the pulmonary, coronary and systemic circulations. Cardiovascular disease includes heart disease, vascular diseases of the brain and kidney, and peripheral arterial diseases. Cardiovascular disease is the leading cause of death globally. Studies on cardiovascular regulation are important to provide a better understanding of this group of diseases and to help improve the corresponding treatment. read more
Products for Cardiovascular
- Acute Phase Reactants(16)
- Angina(14)
- Arrhythmia(82)
- Atherosclerosis(85)
- Cardiomyopathy(5)
- Cholesterol Metabolism(43)
- Chronic Kidney Disease(16)
- Coagulation & Hemostasis(122)
- Coronary Artery Disease(8)
- Diabetic Nephropathy(8)
- Endothelium(32)
- Erythrocytes & Hemoglobin(48)
- Heart Failure(31)
- Hypertension(162)
- Hypotension(21)
- Lipoproteins(61)
- Myocardial Contractility(34)
- Myocardial Hypertrophy(22)
- Myocardial Infarction(61)
- Others(53)
- Serum Proteins(9)
- Smooth Muscle Cells(35)
- Storage & Transport(6)
- Stroke(47)
- Vasoconstriction(58)
- Thrombosis(53)
- Vasodilation(139)
- Cat.No. 产品名称 Information
-
GC41102
15-deoxy-δ12,14-Prostaglandin D2
15deoxyΔ12,14PGD2
A metabolite of PGD2 and an agonist of DP2 - GC40974 16(S)-Iloprost A potent inhibitor of platelet aggregation
- GC40973 16(R)-Iloprost An inhibitor of platelet aggregation
- GC40967 rac-7-methoxy Propranolol An intermediate for the preparation of rac-7-hydroxy propranolol
-
GC40869
CAY10486
4Hydroxycinnamic acid (Lphenylalanine methyl ester) amide
An inhibitor of ACAT -
GC40848
Aspalatone
Acetylsalicylic Acid Matol ester
An antithrombic compound -
GC40835
(±)14(15)-EET methyl ester
(±)14,15EpETrE methyl ester
An esterified version of (±)14(15)-EET -
GC40807
Levonordefrin
(-)-3,4-二羟基去甲麻黄碱,(-)-Cobefrin; (-)-α-Methylnoradrenaline; (-)-Nordefrin
A vasoconstrictor -
GC40799
3-hydroxy-3-Methylglutaric anhydride
3-羟基-3-甲基戊二酸酐
A precursor in the synthesis of HMG-CoA -
GC40782
5(Z),11(Z),14(Z)-Eicosatrienoic Acid
5,11,14,20:3, Sciadonic Acid
A polyunsaturated fatty acid - GC40745 13,14-dehydro-15-cyclohexyl Carbaprostacyclin A stable PGI2 analog
-
GC40709
C2 L-threo Ceramide (d18:1/2:0)
L-threo Cer(d18:1/2:0), L-threo Ceramide (d18:1/2:0), N-acetyl-L-threo-Sphingosine
A bioactive sphingolipid -
GC40708
C2 L-erythro Ceramide (d18:1/2:0)
L-erythro Cer(d18:1/2:0), L-erythro Ceramide (d18:1/2:0), N-acetyl-L-erythro-Sphingosine
A bioactive sphingolipid - GC40632 CMS121 A substituted quinoline with diverse biological activities
-
GC40629
Dimethoxycurcumin
DiMC; CHC 004; Di-O-methylcurcumin
A derivative of curcurmin with anti-inflammatory and antioxidant activities -
GC40624
MMP-3 Inhibitor VIII
Matrix Metalloproteinase-3 Inhibitor VIII, Stromelysin-1 Inhibitor VIII
A selective inhibitor of MMP-3 -
GC40610
Prostaglandin D3
PGD3
An inhibitor of platelet aggregation -
GC40590
ent-8-iso-15(S)-Prostaglandin F2α
ent-15-epi-F2t-Isoprostane, ent-8-iso-15-epi-PGF2α
A vasoconstrictor and inhibitor of platelet aggregation -
GC40586
6β-Prostaglandin I1
6βPGI1, 5,6βdihydro PGI2
A stable PGI2 analog with reduced potency -
GC40585
6α-Prostaglandin I1
6αPGI1, 5,6αdihydro PGI2
A potent inhibitor of ADP-induced platelet aggregation -
GC40555
Tiopronin
BRN 1859822, (±)-Tiopronin
Tiopronin is an antioxidant that has diverse biological activities. -
GC40553
(S)-Acenocoumarol
(S)Acenocoumarin, (S)Nicoumalone
Shorter-lived enantiomer of the anticoagulant acenocoumarol -
GC40552
(R)-Acenocoumarol
(R)Acenocoumarin, (R)Nicoumalone
Longer-lived enantiomer of the anticoagulant acenocoumarol - GC40541 (±)9-HODE A monohydroxy fatty acid derived from linoleic acid
-
GC40535
6,15-diketo-13,14-dihydro Prostaglandin F1α
6,15diketo13,14dihydro PGF1α
A PGI2 metabolite -
GC40529
7-hydroxy Warfarin
7-羟基华法林
A phase I metabolite of (-)-warfarin -
GC40503
2-HOBA
2-羟基苄胺,2-HOBA
An isoketal scavenger -
GC40485
Icosabutate
PRB 01022, PRC 4016
A synthetic ω-3 PUFA -
GC40467
(±)11-HETE
(±)11-Hydroxyeicosatetraenoic Acid
A non-enzymatically derived oxylipin -
GC40457
19(R)-HETE
19(R)-Hydroxyeicosatetraenoic Acid
A potent vasodilator of renal arterioles -
GC40444
(5Z,11Z,15R)-15-Hydroxyeicosa-5,11-dien-13-ynoic Acid
HETE Analog 1, Hydroxyeicosatetraenoic Acid Analog 1
A stable isomer of 15(S)-HETE -
GC40443
(±)9-HETE
(±)9-Hydroxyeicosatetraenoic Acid
A monohydroxy fatty acid -
GC40438
(±)5(6)-EET
(±)-顺式-5,6-环氧-8(Z),11(Z),14(Z)-二十碳三烯酸
A racemic version of a CYP450 metabolite of arachidonic acid -
GC40437
(±)5(6)-DiHET lactone
(±)5,6DiHETrE lactone
A lactone form of (±)5(6)-DiHET -
GC40436
(±)18-HETE
(±)18-Hydroxyeicosatetraenoic Acid
A vasodilator of renal arterioles -
GC40434
(±)16-HETE
(±)16-Hydroxyeicosatetraenoic Acid
A potent inhibitor of proximal tubule ATPase activity -
GC40431
(±)14(15)-EET MaxSpec® Standard
(±)14,15-EET, (±)14,15-EpETrE
An arachidonic acid metabolite -
GC40430
(±)14(15)-EET
(±)14,15-EET, (±)14,15-EpETrE
An arachidonic acid metabolite -
GC40425
14,15-EE-8(Z)-E
14,15Epoxyeicosa8(Z)enoic Acid
A potent vasodilator -
GC40424
14,15-EE-5(Z)-E
14,15Epoxyeicosa5(Z)enoic Acid
An antagonist of EDHF-mediated vasodilation -
GC40421
(±)8(9)-EE-14(Z)-E
(±)8,9-Epoxyeicosa-14(Z)-enoic Acid
A by-product from the synthesis of (±)14(15)-EE-8(Z)-E -
GC40418
5β,6β-epoxy Cholestanol
胆固醇5Β,6Β-环氧化物,NSC 148940
An oxidative metabolite of cholesterol - GC40417 19-hydroxy Cholesterol An oxysterol
-
GC40386
(±)11(12)-EpETE
(±)11,12-EEQ, (±)11,12-Epoxyeicosatetraenoic Acid
Epoxygenase metabolite of EPA - GC40362 (±)18-HEPE Non-enzymatic oxidation product of EPA
- GC40356 (±)9-HpODE A plant oxylipin
-
GC40340
Prostaglandin A1 methyl ester
PGA1 methyl ester
Lipophilic analog of PGA1 -
GC40338
9-deoxy-9-methylene Prostaglandin E2
9deoxy9methylene PGE2
A stable, isosteric analog of PGE2 -
GC40336
5-cis Carbaprostacyclin
(5Z)6aCarbaprostaglandin I2
A stable analog of PGI2 that weakly inhibits platelet aggregation -
GC40268
(±)14(15)-DiHET
(±)14,15DiHETrE
A urinary metabolite of (±)14(15)-EET